Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study
, , , , , , y
15 sept 2024
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 15 sept 2024
Páginas: 335 - 347
Recibido: 13 jun 2024
Aceptado: 14 jul 2024
DOI: https://doi.org/10.2478/raon-2024-0045
Palabras clave
© 2024 Nezka Hribernik et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Hribernik, Nezka
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Strasek, Katja
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Huff, Daniel T
University of Wisconsin Carbone Cancer CentreMadison, USA
Department of Medical Physics, University of Wisconsin-MadisonMadison, USA
Studen, Andrej
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
Experimental Particle Physics Department, Jožef Stefan InstituteLjubljana, Slovenia
Zevnik, Katarina
Department of Nuclear Medicine, Institute of Oncology LjubljanaLjubljana, Slovenia
Skalic, Katja
Department of Nuclear Medicine, Institute of Oncology LjubljanaLjubljana, Slovenia
Jeraj, Robert
Faculty of Mathematics and Physics, University of LjubljanaLjubljana, Slovenia
University of Wisconsin Carbone Cancer CentreMadison, USA
Department of Medical Physics, University of Wisconsin-MadisonMadison, USA
Experimental Particle Physics Department, Jožef Stefan InstituteLjubljana, Slovenia
Rebersek, Martina
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia